¹û¶³Ó°Ôº

XClose

¹û¶³Ó°Ôº-TB

Home
Menu

The Union Conference 2023: ¹û¶³Ó°Ôº presentations

International Union Against Tuberculosis and Lung Disease

¹û¶³Ó°Ôº presentations at The Union annual conference,Ìý15-18 Nov 2023

conference is a major TB research and policy event.Ìý

Below are presentations by ¹û¶³Ó°Ôº-TB affiliated people. All timings are CET.

Wednesday 15th November

Ibrahim AbubakarÌý

Ìý

Panel discussionÌý

WHO Global #EndTB Symposium 2023 Ìý

Panel discussion: Breakthroughs and opportunities to accelerate the TB responseÌý

Wednesday, 15 Nov 2023, 10:30 - 11:20Ìý

Helgard Claassen/ Al LeslieÌý

Oral presentationÌý

OA02 Subclinical TB: How to recognize it when you see it?Ìý

D1: TB epidemiology across the life courseÌý

Ìý

Ìý

OA02-213-15 3-year outcomes in individuals with microbiologically proven sub-clinical TB detected in a population-based survey in rural KwaZulu-Natal, South Africa Ìý

Wednesday, 15 Nov 2023Ìý

11:14 - 11:23Ìý

Ìý

Ibrahim AbubakarÌý

PlenaryÌý

PL-01 Closing the gap between evidence and implementationÌý

Wednesday, 15 Nov 2023, 12:00 - 13:00Ìý

Ìý

Ìý

Gareth HughesÌý

Oral presentationÌý

Ìý

OA06 Safety of regimens for R-RÌý

B3: Clinical trials and operational research for new treatments for TB (for adults and children)Ìý

Ìý

OA06-243-15 Predictive analyses of QT prolongation from ECG monitoring in the STREAM Stage 2 trialÌý

Wednesday, 15 Nov 2023Ìý

15:37 - 15:45Ìý

Angela CrookÌý

SymposiaÌý

SP06 Progress and innovation in developing shorter treatment regimens for people with TBÌý

B3: Clinical trials and operational research for new treatments for TB (for adults and children)Ìý

Ìý

Duration-ranging in Phase 2 trials: UNITE4TB and the MAMS-ROCI DesignÌý

Wednesday, 15 Nov 2023Ìý

15:47 - 16:01Ìý

Andrew NunnÌý

ChairÌý

OA07 Treatment outcome of all oral-short course regimens for RR.TBÌý

B3: Clinical trials and operational research for new treatments for TB (for adults and children)Ìý

Wednesday, 15 Nov 2023Ìý

16:45 - 18:15Ìý

Al StoryÌý

SymposiaÌý

SP10 Providing people-centred TB care for vulnerable populationsÌý

E2: Key affected populations: behavioural, social, and cultural issues and contextsÌý

Ìý

Active case-finding and differentiated care models to accelerate TB elimination among key affected populations in Delhi, IndiaÌý

Wednesday, 15 Nov 2023Ìý

17:04 - 17:18Ìý

Ruth GoodallÌý

Oral presentationÌý

Ìý

OA07 Treatment outcome of all oral-short course regimens for RR.TBÌý

B3: Clinical trials and operational research for new treatments for TB (for adults and children)Ìý

Ìý

OA07-252-15 Long-term outcomes in STREAM Stage 2: A phase 3 trial in rifampicin-resistant TBÌý

Ìý

Wednesday, 15 Nov 2023Ìý

17:26 - 17:35Ìý

Thursday 16th November

Jess PotterÌý

Union Side SessionÌý

Union Side Session: Partnering with Policymakers to Implement UNHLM 2023Ìý

Ìý

08:20 - 08:40 Panel 1: Building a diverse community of advocatesÌý

Thursday, 16 Nov 2023 08:00 - 10:00 CETÌý

Jess PotterÌý

Community ConnectÌý

CC-09 Reflecting and learning from community, academic and health professional engagement with the UN High-Level Meeting on TB for actionable next stepsÌý

Track 3: Political contexts for community led advocacy and accountability Ìý

Ìý

Using our voice to call for change – an academic and health professional's perspectiveÌý

Thursday, 16 Nov 2023Ìý

10:45 - 10:55Ìý

Gabriele PollaraTB ScienceAltered interleukin-6 signalling and risk of TB disease: a meta-analysis and trans-ancestry Mendelian randomisation study

Thursday, 16 Nov 2023Ìý

11:05 - 11:10,ÌýSalle Maillot 5

Sanjib BhaktaTB Science

TBS2C: Host-directed therapyÌý

Anti-inflammatory drugs for TB

Thursday, 16 Nov 2023Ìý

17.13 - 17.23

Friday 17th November

Asad ZaidiÌý

SymposiaÌý

Ìý

SP28 An International Consensus on Early TB (ICE-TB) - the path to programmatic impactÌý

C2: Care and treatment of TB (drug-sensitive and drug-resistant TB)Ìý

Ìý

An International Consensus for Early TB (ICE-TB): Results from the 1st Early TB SymposiumÌý

Friday, 17 Nov 2023Ìý

10:20 - 10:32Ìý

Hanif EsmailÌý

SymposiaÌý

SP28 An International Consensus on Early TB (ICE-TB) - the path to programmatic impactÌý

C2: Care and treatment of TB (drug-sensitive and drug-resistant TB)Ìý

Ìý

Interventions for early TB: Developing interventions for a new frameworkÌý

Friday, 17 Nov 2023Ìý

10:57 - 11:10Ìý

Gabriele PollaraÌý

E-posterÌý

EP17 Immunology for early TB diagnosisÌý

A1: Immunology - research into diagnostics and immunityÌý

Ìý

EP17-1153-17 Altered interleukin-6 signalling and risk of TB disease: A meta-analysis and Mendelian randomisation studyÌý

Friday, 17 Nov 2023Ìý

12:55 - 13:00ÌýSalle Maillot 1

Ankur Gupta-WrightÌý

SymposiaÌý

SP36 New tests for TB screening, diagnosis and treatment monitoring: what do we need?Ìý

A3: TB diagnostics, including drug-resistance determination – Technical aspects and new developmentsÌý

Ìý

Patient-pathway analysis of TB treatment monitoringÌý

Friday, 17 Nov 2023Ìý

16:01 - 16:15Ìý

Hanif EsmailÌý

Satellite sessionÌý

SS17 Rethinking clinical trial design to accelerate improved treatment options for TB-affected communities: Innovative collaborations redefining TB drug and regimen developmentÌý

B3: Clinical trials and operational research for new treatments for TB (for adults and children)Ìý

UNITE4TB-01: A new PARADIGM of evaluating novel drugsÌý

Friday, 17 Nov 2023Ìý

Session:Ìý18:30 – 20:00

18:49 - 18:56Ìý

Saturday 18th November
Stella FabianeOral presentationÌý

OA59 TB control: from diagnosis to treatment outcome

OA59-667-18 Does the choice of fluoroquinolone affect treatment outcomes in rifampicin-resistant TB?

Saturday, 18 Nov 2023Ìý

08:11Ìý- 08:20Ìý

Ruth GoodallÌý

Ìý

Oral presentationÌý

Ìý

OA59 TB control: from diagnosis to treatment outcomeÌý

C2: Care and treatment of TB (drug-sensitive and drug-resistant TB)Ìý

Ìý

OA59-663-18 Creating a global individual patient data platform for TB treatment, TB-IPDÌý

Saturday, 18 Nov 2023Ìý

08:35 - 08:44Ìý

Ìý

Ìý